Aslan Pharmaceuticals Pte. Ltd. has raised a total of $34m in a Series C financing involving existing and new investors, which it will use mainly to progress its pipeline. The new round takes the to
Business: Minimally invasive benign prostatic hyperplasia treatment As men age, enlargement of the prostate gland is almost as inevitable as gray hair; 30% of men over the age of 50 will develop sympt